Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugsJennifer Kouznetsova, Adolfo García‐Sastre, Wei Sun et al.|Emerging Microbes & Infections|2014Cited by 242
An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivoCraig Cherrin, Hans E. Huber, Thomayant Prueksaritanont et al.|Cancer Biology & Therapy|2010Cited by 59
Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 TreatmentAmy Q. Wang, Xin Xu, Natalie R. Hagen et al.|Frontiers in Pharmacology|2022Cited by 31
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19Jonathan H. Shrimp, Matthew D. Hall, John Janiszewski et al.|ACS Infectious Diseases|2022Cited by 8
Preclinical Pharmacokinetics and <i>In Vitro</i> Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 TreatmentAmy Q. Wang, Xin Xu, Natalie R. Hagen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2